FourThought Financial, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
FourThought Financial, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2022$82,000
+12.3%
1,1130.0%0.01%
+9.1%
Q2 2022$73,000
+14.1%
1,113
+9.4%
0.01%
+37.5%
Q1 2022$64,000
+30.6%
1,017
+10.4%
0.01%
+33.3%
Q4 2021$49,000
-24.6%
9210.0%0.01%
-33.3%
Q3 2021$65,000
+140.7%
921
+123.0%
0.01%
+125.0%
Q2 2021$27,000
-42.6%
413
-2.8%
0.00%
-42.9%
Q1 2021$47,000
-11.3%
425
-6.2%
0.01%
-12.5%
Q4 2020$53,0004530.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders